A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the safety profile of SH3051 in subjects with advanced
solid tumors. The second objective is to evaluate the PK profile and preliminary efficacy of
SH3051 solid tumors.